Abstract
Objective: To determine and compare the effects of Theraband exercises with Incentive Spirometer exercise in improving respiratory muscle strength among bronchial asthma.
 Methods: In this study, 30 Individuals with Bronchial asthma were taken and assessed for FEV1/FVC, Maximum voluntary ventilation (MVV) using a computerized spirometer, dyspnea level graded using MMRC scale and diaphragm muscle strength assessed using manual muscle testing (MMT) as pre-test then the individuals were randomly allocated in two groups: Group A and Group B. Group A (n=15) received Theraband exercise and Group B (n=15) were treated with incentive spirometer for a total period of 4 w following which the outcome measures were repeated for post-test.
 Results: Based on the obtained statistics, both the groups showed significant improvement within groups when comparing pre and post-test measures. On comparing the mean values of the post-test between the groups, theraband exercises showed clinically higher significant results than incentive spirometer exercises.
 Conclusion: From the result, it shall been concluded that both theraband exercises and incentive spirometer exercises shows improvement in MVV, FEV1/FVC, reduced dyspnea and increased respiratory muscle strength. Hence, theraband exercises are effective compared to the incentive spirometer.
Highlights
Bronchial asthma is an atopic disease, it affects around 7% of the population, and 300 million people are affected worldwide
This study introduces the application of Theraband exercises in the strengthening of respiratory muscles in bronchial asthma individuals
Mean and the standard deviation was calculated for different parameters in pre test and post test
Summary
Bronchial asthma is an atopic disease, it affects around 7% of the population, and 300 million people are affected worldwide. The disease is characterized by chronic airway inflammation and increased airway hyperresponsiveness which presents the symptoms of wheeze, cough and dyspnea. It is known that the prevalence of Asthma is increasing steadily in recent years, especially in countries with a western lifestyle and in developing countries [1]. In India the estimated prevalence rate is about 3% which is nearly 30 million patients consists of 2.4% adults and 4%-20% children’s [2]. The patients who under-estimate their symptoms are under high risk. About 15-20% of asthmatics individuals are unnoticed of moderate changes in their airflow obstruction and which may quickly deteriorate until they suddenly present with severe asthma [3]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Current Pharmaceutical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
